LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Net, Noncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Deferred Tax Assets, Net, Noncurrent of $138.84 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsLiabilitiesNetNoncurrent · last filed 2017-08-09
- 2017-06-30: Deferred Tax Assets, Net, Noncurrent $138.84M.
- 2017-03-31: Deferred Tax Assets, Net, Noncurrent $141.01M.
- 2016-12-31: Deferred Tax Assets, Net, Noncurrent $123.89M.
- 2016-09-30: Deferred Tax Assets, Net, Noncurrent $133.49M.
| Period end | Deferred Tax Assets, Net, Noncurrent | Deferred Tax Assets, Net, Noncurrent as first filed |
|---|---|---|
| 2017-06-30 | $138.84M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $141.01M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $123.89M 10-Q · filed 2017-08-09 | |
| 2016-09-30 | $133.49M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $133.59M 10-Q · filed 2016-11-14 | $161.08M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $129.78M 10-Q · filed 2016-11-14 | $157.26M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $189.08M 10-K · filed 2017-02-28 | $216.56M 10-K · filed 2016-02-26 |
| 2015-09-30 | $181.05M 10-Q · filed 2016-11-14 | $206.42M 10-Q · filed 2015-11-09 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-09 |